Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03210038
Other study ID # 0290-16-ASF
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2017
Est. completion date December 1, 2019

Study information

Verified date December 2019
Source Assaf-Harofeh Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Women arriving to the Urology department outpatient clinic at Assaf-Harofeh Medical Center in order to undergo a cystoscopy examination will be recruited.

Patients will be randomly assigned to one of four groups by method of cystoscopy (flexible and rigid) and by use of anesthesia to the introitus.

Pain levels will be recorded prior to the examination, during entrance of the cystoscope in the urethral meatus, immediately after the examination and 15 minutes after conclusion.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date December 1, 2019
Est. primary completion date December 1, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All women referred to elective outpatient cystoscopy.

Exclusion Criteria:

- Known urethral stricture.

- Known allergy to lubricant/anesthesia gel.

- Patients under the age of 18 (minors).

- Patients with current Urinary Tract Infections.

- Chronic pelvic pain (e.g Interstitial Cystitis/Bladder Pain Syndrome.

- Known neurlogical or other chronic pain syndrome requiring chronic analgesia medication.

- Mentally incapable for consensual agreement of participation.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Lidocaine
Pad soaked with lidocaine gel (Esracaine) left on the introitus for 5 minutes
Water
Water based non-anesthetic lubricant gel left on the introitus for 5 minutes.

Locations

Country Name City State
Israel Assaf Harofe Medical Center Be'er Ya'aqov

Sponsors (1)

Lead Sponsor Collaborator
Assaf-Harofeh Medical Center

Country where clinical trial is conducted

Israel, 

References & Publications (4)

Aaronson DS, Walsh TJ, Smith JF, Davies BJ, Hsieh MH, Konety BR. Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief? BJU Int. 2009 Aug;104(4):506-9; discussion 509-10. doi: 10.1111/j.1464-410X.2009.08417.x. Epub 2009 Feb 23. — View Citation

Patel AR, Jones JS, Babineau D. Lidocaine 2% gel versus plain lubricating gel for pain reduction during flexible cystoscopy: a meta-analysis of prospective, randomized, controlled trials. J Urol. 2008 Mar;179(3):986-90. doi: 10.1016/j.juro.2007.10.065. Ep — View Citation

Seklehner S, Remzi M, Fajkovic H, Saratlija-Novakovic Z, Skopek M, Resch I, Duvnjak M, Hruby S, Librenjak D, Hübner W, Breinl E, Riedl C, Engelhardt PF. Prospective multi-institutional study analyzing pain perception of flexible and rigid cystoscopy in me — View Citation

Stav K, Ohlgisser R, Siegel YI, Beberashvili I, Padoa A, Zisman A. Pain during Female Urethral Catheterization: Intraurethral Lubricant Injection versus Catheter Tip Lubrication--A Prospective Randomized Trial. J Urol. 2015 Oct;194(4):1018-21. doi: 10.101 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain before procedure Pain measurement using a 0-10 visual analogue scale (VAS) and comparison of average pain score between the four study groups. Before cystoscopy
Primary Pain during meatus insertion of cystoscope Pain measurement using a 0-10 visual analogue scale (VAS) and comparison of average pain score between the four study groups. During the procedure, at the moment of cystoscopy insertion through the urethra
Primary Pain immediately after procedure Pain measurement using a 0-10 visual analogue scale (VAS) and comparison of average pain score between the four study groups. Immediately after withdrawal of the cystoscope from the urethra
Primary Pain 15 minutes after procedure Pain measurement using a 0-10 visual analogue scale (VAS) and comparison of average pain score between the four study groups. 15 minutes after end of procedure
See also
  Status Clinical Trial Phase
Recruiting NCT05415865 - The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder Phase 3
Active, not recruiting NCT03988309 - STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA N/A
Completed NCT05011253 - Electronic Triggers: Microhematuria Trigger N/A
Completed NCT02276924 - Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors N/A
Active, not recruiting NCT04943380 - Efficacy and Utility of Cxbladder Tests in Hematuria Patients
Recruiting NCT05646485 - Bladder Cancer Screening Trial N/A
Recruiting NCT06026189 - Safely Reduce Cystoscopic Evaluations for Hematuria Patients N/A
Active, not recruiting NCT03122964 - Multi Institutional Study in Patient Presenting With Hematuria
Completed NCT02381912 - Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer N/A
Completed NCT01812928 - Diclofenac Suppository to Control Pain During Flexible Cystoscopy Phase 2
Active, not recruiting NCT01563796 - Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer N/A
Terminated NCT00600691 - The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy Phase 2
Completed NCT00231322 - Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique N/A
Completed NCT05314582 - Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia
Recruiting NCT05620784 - Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP Phase 3
Completed NCT04555343 - Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention Phase 1/Phase 2
Completed NCT04317261 - Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria N/A
Not yet recruiting NCT06427993 - Urine DNA Methylation Detection for Hematuria Evaluation
Recruiting NCT03965975 - Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device N/A
Not yet recruiting NCT05893316 - UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study